London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel
So thrilled that Perceptic are finally out of stealth, today announcing their $12m seed round led by Accel, alongside Air Street Capital & ourselves at Elder Gull! …